Viewing Study NCT06120504

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:08 PM
Ignite Modification Date: 2026-01-24 @ 3:17 PM
Study NCT ID: NCT06120504
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-14
First Post: 2023-11-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, T-Cell, Cutaneous View
None Hodgkin Disease View
None Lymphoma, T-Cell, Peripheral View
None Lymphoma, Large-Cell, Anaplastic View
None Lymphoma, Large B-Cell, Diffuse View
None Lymphoma, Non-Hodgkin View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cHL View
None ALCL View
None PCL View
None PTCL View
None DLBCL View
None CTCL View
None Non-Hodgkin Lymphoma View
None Seattle Genetics View